CASI Pharmaceuticals says SVP Wei (Larry) Zhang steps down
Reuters2026/08/13 20:38- CASI Pharmaceuticals reported that Wei (Larry) Zhang will no longer serve as senior vice president.
- The move was tied to efforts to streamline branches, personnel, and related activities in the United States.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cantex Mine Development closes second tranche of private placement for $1.01 million proceeds
PVH CEO Stefan Larsson acquires USD 999,999 of common shares
The rebound of the yen may only be temporary, Morgan Stanley bets on arbitrage trades making a comeback, USD/JPY expected to rise to 163.
Morgan Stanley believes that the recent strengthening of the Japanese yen is mainly due to the unwinding of short-term arbitrage trades and market bets on Japanese capital repatriation, rather than any substantial improvement in fundamentals.

Edwards Lifesciences CVP, TAVR Daniel J. Lippis disposes of 619 common shares worth $54,168.69